Adage Capital Partners’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$145K | – | 906 |
|
|
2024
Q1 | $145K | Sell |
50,000
-50,000
| -50% | -$145K | ﹤0.01% | 820 |
|
|
2023
Q4 | $735K | Sell |
100,000
-95,000
| -49% | -$698K | ﹤0.01% | 772 |
|
|
2023
Q3 | $1.5M | Buy |
195,000
+20,000
| +11% | +$154K | ﹤0.01% | 749 |
|
|
2023
Q2 | $1.77M | Sell |
175,000
-30,000
| -15% | -$304K | ﹤0.01% | 743 |
|
|
2023
Q1 | $1.99M | Buy |
205,000
+130,000
| +173% | +$1.26M | ﹤0.01% | 765 |
|
|
2022
Q4 | $364K | Hold |
75,000
| – | – | ﹤0.01% | 867 |
|
|
2022
Q3 | $1.07M | Sell |
75,000
-10,000
| -12% | -$143K | ﹤0.01% | 888 |
|
|
2022
Q2 | $460K | Sell |
85,000
-65,000
| -43% | -$352K | ﹤0.01% | 940 |
|
|
2022
Q1 | $971K | Sell |
150,000
-164,000
| -52% | -$1.06M | ﹤0.01% | 935 |
|
|
2021
Q4 | $5.08M | Buy |
+314,000
| New | +$5.08M | 0.01% | 815 |
|